These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 17631693)

  • 1. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
    Hemphill A; Spicher M; Stadelmann B; Mueller J; Naguleswaran A; Gottstein B; Walker M
    Parasitology; 2007 Nov; 134(Pt 12):1657-70. PubMed ID: 17631693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options.
    Hemphill A; Müller J
    J Helminthol; 2009 Jun; 83(2):99-111. PubMed ID: 19296876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of echinococcosis: albendazole and mebendazole--what else?
    Hemphill A; Stadelmann B; Rufener R; Spiliotis M; Boubaker G; Müller J; Müller N; Gorgas D; Gottstein B
    Parasite; 2014; 21():70. PubMed ID: 25526545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.
    Hemphill A; Stadelmann B; Scholl S; Müller J; Spiliotis M; Müller N; Gottstein B; Siles-Lucas M
    Parasitology; 2010 Mar; 137(3):569-87. PubMed ID: 19765346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of Alveolar and Cystic Echinococcosis (AE and CE).
    Gottstein B; Soboslay P; Ortona E; Wang J; Siracusano A; Vuitton DΑ
    Adv Parasitol; 2017; 96():1-54. PubMed ID: 28212788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?
    Vuitton DA
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):145-9. PubMed ID: 19254162
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
    Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
    Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the immunology and diagnosis of echinococcosis.
    Zhang W; McManus DP
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):24-41. PubMed ID: 16706785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
    Stadelmann B; Rufener R; Aeschbacher D; Spiliotis M; Gottstein B; Hemphill A
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004535. PubMed ID: 26967740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.
    Brunetti E; Kern P; Vuitton DA;
    Acta Trop; 2010 Apr; 114(1):1-16. PubMed ID: 19931502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
    María AC; Celina EM
    Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis.
    Bull World Health Organ; 1996; 74(3):231-42. PubMed ID: 8789923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.
    Siles-Lucas M; Casulli A; Cirilli R; Carmena D
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006422. PubMed ID: 29677189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for the treatment of alveolar echinococcosis: Where are we?
    Autier B; Robert-Gangneux F; Dion S
    Parasite; 2024; 31():56. PubMed ID: 39311470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular survival strategies of Echinococcus multilocularis in the murine host.
    Gottstein B; Haag K; Walker M; Matsumoto J; Mejri N; Hemphill A
    Parasitol Int; 2006; 55 Suppl():S45-9. PubMed ID: 16352460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.
    Küster T; Stadelmann B; Aeschbacher D; Hemphill A
    Int J Antimicrob Agents; 2014 Apr; 43(4):335-42. PubMed ID: 24646943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status and prospect of novel treatment options toward alveolar and cystic echinococcosis.
    Wang S; Ma Y; Wang W; Dai Y; Sun H; Li J; Wang S; Li F
    Acta Trop; 2022 Feb; 226():106252. PubMed ID: 34808118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles.
    Spiliotis M; Lechner S; Tappe D; Scheller C; Krohne G; Brehm K
    Int J Parasitol; 2008 Jul; 38(8-9):1025-39. PubMed ID: 18086473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
    Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
    Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the importance of targeting parasite stem cells in anti-echinococcosis drug development.
    Brehm K; Koziol U
    Parasite; 2014; 21():72. PubMed ID: 25526547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.